Pall 血清替代物 20ml Ultroser™ G serum substitute

血清替代品產(chǎn)品介紹：
Ultroser™ G可以在細(xì)胞培養(yǎng)基中成功替代FCS(胎牛血清)。Ultroser™ G設(shè)計(jì)用于依賴貼壁細(xì)胞的體外培養(yǎng)。已在羊膜液細(xì)胞原代培養(yǎng)中測試過，旨在確認(rèn)其核型分析能力。Ultroser G通過CE標(biāo)記注冊。
Ultroser G通過一系列質(zhì)量測試，包括PH、蛋白質(zhì)濃度、無菌控制、細(xì)菌和真菌、牛病毒（BHV1-DVB/MM,紅細(xì)胞吸附）、支原體、Hep G2細(xì)胞增殖能力、核型分析等。

產(chǎn)品特性：
» 半固定成份確保批次間可重現(xiàn)性
» 低蛋白含量
» 方便使用和保藏
» Ultroser G濃度是胎牛血清濃度的5倍（2%相當(dāng)于10%胎牛血清）

Pall 血清替代物 20ml Ultroser™ G serum substitute

英文簡述：
Ultroser™ G serum substitute can successfully replace FCS (fetal calf serum) in cell culture medium. It is designed for the in vitro culture of anchorage-dependent cells. It is specially tested as the primary culture from amniotic liquid cells and is designed to confirm their ability for karyotyping. Ultroser G serum substitute is CE mark-certified.
Ultroser G serum substitute has a concentration five times higher than fetal calf serum (2 % of reconstituted Ultroser G serum substitute is equivalent to 10%  fetal calf serum in the basal medium).

Quality Control Tests
Tests usually performed on Ultroser G serum substitute are:
● Physicochemical parameters pH
● Protein concentration
● Sterility control
● Bacteria & Fungi
● Bovine viruses (BHV1-DVB/MM, hemadsorbents)
● Proliferation capacity on Hep G2
● Mycoplasma
● Karyotyping